Nidufexor, formerly known as LMB 763, is a novel, potent and orally bioactive farnesoid X receptor (FXR) agonist. Nidufexor has the potential for treating of nonalcoholic steatohepatitis (NASH).
纯度：≥98%
CAS：1773489-72-7
m.cnreagent.com
